期刊文献+

成纤维细胞生长因子受体3突变与疾病

下载PDF
导出
摘要 成纤维细胞生长因子受体3(FGFR3)在细胞的增殖、分化、血管形成、骨骼发育及与生长和发育相关的过程中起着十分重要的作用。本文概述了FGFR3突变与遗传性侏儒症、膀胱癌等肿瘤的发生和发展的关系。
机构地区 浙江大学医学院
出处 《国外医学(遗传学分册)》 2004年第4期252-256,共5页 Foreign Medical Sciences(Section of Genetics )
  • 相关文献

参考文献36

  • 1Tavormina PL, Bellus GA, Webster MK, et al. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3gene. Am J Hum Genet, 1999,64(3):722-731.
  • 2Chesi M, Nardini E, Brents LA, et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor3. Nat Genet, 1997,16(3):260-264.
  • 3van Rhijn BW, Vis AN, van der Kwast TH, et al. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol, 2003,21(10):1912-1921.
  • 4Hecht D, Zimmerman N, Bedford M, et al. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.Growth Factors, 1995, 12(3): 223-233.
  • 5Thompson LM, Raffioni S, Wasmuth JJ, et al. Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12cells. Mol Cell Biol, 1997,17(7):4169-4177.
  • 6Raffioni S, Zhu YZ, Bradshaw RA, et al. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation. J Biol Chem, 1998,273(52):35
  • 7(3): 1465-1469.2.Chellaiah AT, McEwen DG, Werner S, et al. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain Ⅲ creates a receptor highly specific for acidic FGF/FGF-1.J Biol Chem, 1994,269(15): 11620-11627.
  • 8Tavormina PL, Rimoin DL, Cohn DH, et al. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type Ⅰ. Hum Mol Genet, 1995,4(11): 2175-2177.
  • 9Stoilov I, Kilpetrick MW, Tsipouras P, et al. Possible genetic heterogeneity in hypochondroplasia. J Med Genet, 1995,32(6): 492-493.
  • 10Ornitz DM, Itoh N. Fibroblast growth factors. Genome-Biol, 2001,

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部